Recombinant Macaca fascicularis Signal Peptidase Complex Subunit 2 (SPCS2) is a synthetically produced protein derived from the Macaca fascicularis, also known as the cynomolgus monkey or crab-eating macaque . SPCS2 is a subunit of the signal peptidase complex (SPC), an enzyme crucial for protein maturation in eukaryotic cells .
The signal peptidase complex (SPC) is responsible for cleaving signal peptides from precursor proteins, a necessary step for proper protein folding and localization . SPCS2 plays a vital role in the function of the SPC . Research indicates that SPCS2 modulates the substrate and cleavage site selection within the SPC . Specifically, it has been shown that the absence or mutation of Spc2 compromises the SPC's ability to discriminate between substrates and identify cleavage sites .
SPCS2 affects the SPC's preference for signal sequences based on their length . SPCS2 promotes the cleavage of signal sequences with short n-regions (N < 16) and reduces cleavage of those with long n-regions . The C-terminal domain of Spc2 may prevent signal sequences with long n-regions from entering the transmembrane window, making shorter signal peptides preferable substrates for the SPC .
The Macaca fascicularis is a key non-human primate model in biomedical research because of its physiological similarities to humans . They are used in reproductive studies, pharmaceutical research, infectious disease research, and cardiovascular studies . Their use helps researchers to ensure that new drugs are safe and effective and to understand various diseases .
Recombinant SPCS2 is utilized in research applications to study protein biogenesis and the function of the signal peptidase complex . It can be used in in vitro assays and structural studies to elucidate the mechanisms by which SPC governs protein processing .
Recombinant SPCS2 is produced through synthetic means and is available for purchase from various suppliers . The protein is expressed, purified, and stored in specific buffers to maintain its stability and activity .
The human SPCS2 gene, for example, is identified by the Gene ID: 9789 . Orthologs of human protein-coding genes, including SPCS2, have been identified in the Macaca fascicularis genome, which aids in the design of species-specific research tools .
SPCS2 has been linked to certain diseases . For example, Spinocerebellar Ataxia 13 is associated with the SPCS2 gene . Further research is needed to fully understand the implications of SPCS2 dysfunction in disease development.
The following tables summarize key data related to SPCS2:
| Property | Description |
|---|---|
| Name | Signal Peptidase Complex Subunit 2 |
| Organism | Macaca fascicularis (Cynomolgus monkey) |
| Function | Modulates substrate and cleavage site selection in the signal peptidase complex |
| участвует в | Protein maturation, protein folding, and localization |
| Связанные заболевания | Spinocerebellar Ataxia 13 |
A component of the microsomal signal peptidase complex, responsible for removing signal peptides from nascent proteins during their translocation into the endoplasmic reticulum lumen.
KEGG: mcf:102116673
UniGene: Mfa.8492
Signal Peptidase Complex Subunit 2 (SPCS2) is a critical component of the Signal Peptidase Complex (SPC) responsible for cleaving signal sequences from secretory proteins. In Macaca fascicularis, as in other eukaryotes, SPCS2 helps distinguish between signal peptides (SPs) and signal-anchored (SAs) sequences, ensuring proper protein processing in the endoplasmic reticulum. Research indicates that SPCS2 modulates the properties of the SPC and its surrounding membrane environment, enhancing the complex's ability to discriminate between these sequences .
The C-terminal cytosolic domain of SPCS2 plays a particularly important role in substrate recognition, as demonstrated in research with the yeast ortholog (Spc2), where this domain was found to be crucial for N-length dependent substrate selection by SPC .
SPCS2 significantly influences membrane architecture around the SPC. Coarse-grained molecular dynamics (CGMD) simulations of SPC structures show that when SPCS2 is present, it induces membrane thinning at the center of the complex (known as the TM-window). This thinned region is approximately 3Å thinner than in structures lacking SPCS2 .
This membrane modulation is functionally significant as it affects which substrates can access the active site:
Shorter signal peptides fit well in the thinned membrane with SPCS2 present
Longer hydrophobic regions are accommodated better when SPCS2 is absent and the membrane is thicker
Recombinant SPCS2 from Macaca fascicularis is characterized by specific functional domains that influence its role in the signal peptidase complex:
Transmembrane Domain: Contains transmembrane segments that anchor the protein in the ER membrane
C-terminal Cytosolic Domain: Critical for substrate discrimination and recognition
Catalytic Region: While not directly containing the catalytic site, SPCS2 influences accessibility to the active site of the complex
The AlphaFold2-predicted structures of SPCS2 (based on studies of the yeast ortholog) show that it constitutes a significant portion of the cytosolic part of SPC, positioning it ideally to interact with the N-terminal regions of signal sequences as they emerge from the translocon .
Recombinant Macaca fascicularis SPCS2 can be produced using several expression systems, each with specific advantages for research applications:
| Expression System | Advantages | Typical Yield | Post-translational Modifications |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid expression | High | Minimal/None |
| Yeast | Proper folding, some PTMs | Moderate | Basic eukaryotic modifications |
| Baculovirus | High-level expression of complex proteins | Moderate-High | Advanced eukaryotic modifications |
| Mammalian cell | Most native-like protein structure and PTMs | Lower | Full range of mammalian modifications |
For studies focusing on structural analysis without requiring post-translational modifications, E. coli systems typically provide sufficient protein quality. For investigations requiring native-like protein behavior, mammalian expression systems are recommended despite their lower yield .
Investigating SPCS2's role in signal sequence discrimination requires a multifaceted experimental approach:
Deletion and Mutation Studies:
Generate SPCS2 knockout or knockdown models in cell lines
Create specific domain mutations, particularly in the C-terminal domain
Assess how these alterations affect signal sequence processing
Model Substrate Analysis:
Design model substrates with varying N-region lengths (the segment preceding the hydrophobic core of signal sequences)
Compare processing of substrates with short N-regions (N# < 16) versus long N-regions (N# > 16)
Pulse-labeling experiments can capture early stages of protein maturation
Molecular Dynamics Simulations:
Research has shown that SPCS2 promotes cleavage of signal sequences with short N-regions while reducing cleavage of those with long N-regions, suggesting it sharpens discrimination between signal peptides and signal-anchored sequences .
The interaction between SPCS2 and the Sec61 translocon can be studied using these approaches:
Co-immunoprecipitation (Co-IP):
Use antibodies against SPCS2 or Sec61β subunit to pull down protein complexes
Analyze interacting partners by Western blotting or mass spectrometry
Proximity Labeling:
Utilize BioID or APEX2 tagging of SPCS2
Identify proximal proteins through streptavidin pulldown and mass spectrometry
Crosslinking Studies:
Apply chemical crosslinkers to stabilize transient interactions
Analyze crosslinked complexes to map interaction sites
Functional Assays:
Assess signal sequence processing in cells with mutated SPCS2-translocon interfaces
Monitor the unfolded protein response (UPR) activation as an indicator of compromised processing
Previous research has shown that SPCS2 interacts with the β subunit of the Sec61 translocon in yeast and mammals, mediating transient interactions between the SPC and the translocon .
Research using 2b-RAD simplified genome sequencing analyzed 55 laboratory macaques (40 cynomolgus macaques and 15 rhesus macaques) bred in South China. The findings revealed:
Laboratory macaques generally showed relatively low genetic diversity at the genomic level
Genetic differentiation in Chinese rhesus macaques was higher than in cynomolgus macaques
Introgressive hybridization with Chinese rhesus macaques was detected in more than 80% (32/40) of cynomolgus macaques
These patterns likely extend to the SPCS2 gene, suggesting that researchers should be aware of potential genetic variation when using different macaque species for SPCS2 studies. Hybrid introgression may particularly affect genes involved in protein processing pathways, potentially including SPCS2 .
When comparing SPCS2 between Macaca fascicularis and humans, researchers should consider:
Sequence Conservation:
Functional Conservation:
Both proteins play similar roles in signal sequence processing
The cytosolic domains constitute a major part of the respective SPCs
Species-Specific Differences:
Subtle variations may exist in substrate specificity
Differences in interaction networks with other cellular components
Understanding these differences is crucial when using macaque models for translational research, as they may affect the interpretation of experimental results and their applicability to human biology .
Recombinant SPCS2 can serve as a valuable tool in vaccine research using macaque models:
As a Carrier Protein or Fusion Partner:
SPCS2 can be used as a fusion partner for antigenic epitopes
The proper folding and processing of such fusion proteins depends on understanding SPCS2 function
For Studying Immune Responses:
In Comparative Immunology:
The efficacy and safety of recombinant protein vaccines in macaques have been demonstrated in previous studies, where intramuscular administration with aluminum hydroxide adjuvant elicited strong immune responses without discernible adverse effects .
Analyzing post-translational modifications (PTMs) of SPCS2 requires sophisticated methodologies:
Mass Spectrometry-Based Approaches:
Enrichment strategies for specific PTMs (phosphorylation, glycosylation, etc.)
Bottom-up proteomics for identification of modification sites
Top-down proteomics for intact protein analysis with modifications
Comparative Analysis:
Compare PTM patterns between recombinant and native SPCS2
Assess differences between SPCS2 from different expression systems
Functional Impact Assessment:
Site-directed mutagenesis of potential PTM sites
Analysis of how PTM changes affect SPCS2's role in signal sequence processing
Investigation of how PTMs influence SPCS2's interaction with other SPC components
For recombinant SPCS2 production, the choice of expression system significantly impacts the PTM profile. E. coli-expressed protein will lack eukaryotic modifications, while mammalian cell-expressed protein will most closely resemble the native state .
Poor solubility is a common challenge when working with membrane proteins like SPCS2. Researchers can employ several strategies:
Optimization of Expression Conditions:
Lower induction temperature (16-20°C)
Reduced inducer concentration
Extended, slow induction period
Solubility-Enhancing Tags and Partners:
Buffer Optimization:
Include glycerol (typically 10-50%) to stabilize the protein
Test various detergents for membrane protein solubilization
Optimize salt concentration and pH
Expression of Functional Domains:
Express only the cytosolic domain for interaction studies
Use truncation constructs lacking transmembrane segments
Commercial recombinant SPCS2 preparations often use strategies like His-SUMO tagging and glycerol-containing formulations (up to 50% glycerol) to maintain solubility and stability .
Validating antibody specificity for SPCS2 requires rigorous testing:
Western Blot Analysis:
Test against recombinant SPCS2 and macaque tissue/cell lysates
Include negative controls (knockout or knockdown samples)
Compare with known SPCS2 molecular weight patterns (typically ~25 kDa)
Immunoprecipitation Followed by Mass Spectrometry:
Confirm identity of pulled-down proteins
Check for expected SPCS2 peptides in the mass spectrum
Cross-Reactivity Testing:
Test against related proteins to ensure specificity
Assess cross-reactivity with human SPCS2 and other macaque species
Immunofluorescence with Subcellular Markers:
Co-localization with ER markers (SPCS2 should localize to the ER membrane)
Absence of signal in SPCS2-depleted cells
Previous immunological studies in macaques have employed rigorous validation protocols, including testing antisera against both recombinant proteins and native proteins in cell/tissue extracts, as well as immunofluorescence localization studies .